“This should be a really joyous time because we now have highly effective antiviral pills,” Erin McCreary, a pharmacist and administrator at the University of Pittsburgh Medical Center, told the Associated Press. “Instead, this feels like the hardest and most chaotic stretch of the pandemic.”…

Pfizer said it will only have 250,000 courses of the treatment by the end of January for US patients. The first 10 million doses won’t be available until June.

“We expect to use our strong manufacturing capabilities and our extensive supplier network to continue to improve output rapidly,” Pfizer, which delivered around 160,000 doses of the pill in December, said in a statement to the AP.